Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.
about
The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future researchWhy does obesity promote cancer? Epidemiology, biology, and open questionsUse of metformin and survival of diabetic women with breast cancerThe diabetes-cancer linkEffects of insulin on human pancreatic cancer progression modeled in vitroAssessing the effect of treatment duration on the association between anti-diabetic medication and cancer riskDiabetes mellitus and colorectal cancer prognosis: a meta-analysisHigh glucose promotes gastric cancer chemoresistance in vivo and in vitroAre metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro.Diabetes and Breast Cancer Subtypes.Colon cancer modulation by a diabetic environment: A single institutional experience.Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.Diabetes and risk of cancer.Association between metformin therapy and mortality after breast cancer: a population-based study.Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study.Excess adiposity and survival in patients with colorectal cancer: a systematic review.The epidemiology of diabetes and cancer.Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example UrolithiasisInsights into the relationships between diabetes, prediabetes, and cancer.Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A.A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in TaiwanAssociation between large detectable clonal mosaicism and type 2 diabetes with vascular complications.Demographic Characteristics, Survival and Prognostic Factors of Early Breast Cancer Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort StudyPre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia.Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells.Zinc and its transporter ZIP6 are key mediators of breast cancer cell survival under high glucose conditions.Exploratory study of impact of cancer-related posttraumatic stress symptoms on diabetes self-management among cancer survivors.Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.Comorbidity, Physical Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia.The association between diabetes and breast cancer stage at diagnosis: a population-based study.Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes.Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
P2860
Q26782839-1A0E274F-E530-4E76-89E6-048F2D6CCA08Q26797301-27618BE7-478F-4520-8814-12719175AB1DQ33646542-EAA7D120-973B-4907-A44D-628F5076E468Q34510892-4FAD48C8-3535-42E6-A8DE-7CB7FBA27FFBQ34517664-EDFACF89-F356-43A4-A875-7062575662EFQ34565654-C1DC2CB4-AA58-43D1-BDDD-F19C1AFFDFA1Q34656583-D7466110-8FCC-440D-8C2C-FFF6A727A668Q35628554-F49C7548-61C7-4773-9A7A-C72D46A5B924Q35909683-B1950488-12BE-4535-9B1C-1AFD929824DFQ35937961-8436118E-DEAD-4379-BBA0-5BFB212E7588Q36208187-263F6E2C-E530-40C1-AA23-FB8D837B12D1Q36246468-EE5E2780-7659-45AE-BAE8-F0C19CDC8657Q36295273-92592789-1FA9-4D48-935F-8B17ED82BEF3Q36334462-7E6BC9AE-6A1E-4BD5-B56E-C8BC916A75A2Q36637909-5960A8C9-E42C-43D8-A40C-97E0A57788C4Q37193432-149D4B22-A1C9-498B-9A13-97DE289CE3CCQ37193648-A869EE15-FCF5-4894-9B13-1155FBF3B333Q38179065-50BD44B3-C606-4D8A-A316-2C1C7F7FD8BAQ38243241-8150A094-DDD8-4855-B8AE-9E465ECFBB99Q38248399-F30D64DD-C862-420B-B211-F2BBBC3C6B2DQ38374279-5BFF86C3-1380-4EEC-A3D2-8F66E68080BEQ38624936-12717B12-C55E-47F9-8FAB-F0F15CF976C5Q39063925-F309189E-1774-41C8-B54E-81F5AD19D536Q41308580-8F186315-4F7B-4FC5-AD5A-16AEC3743400Q42684852-089F52DB-E8D7-464C-941D-38022A2E1190Q45809254-4BA52E01-D9CC-4D15-B012-2EB878487E78Q47096644-57BE0764-0B66-4870-9456-952D55879C06Q47238502-6AA0327F-D934-4509-9FBD-6A9ECFC01CBBQ47371109-34B0408A-8853-4E77-B95D-B11BEBED11C0Q47795004-B4023E24-0CDD-43D8-87D5-D3A56A309BFBQ48152525-298EA4D7-3AB8-4610-8A55-0740D0FDE940Q49873927-899785A9-4484-4B85-B381-0264BD3A0768Q50234387-E30AB6C1-B95F-42B9-9150-21B347E7398EQ50947162-8D474C86-2028-48C0-A58D-5A1BD113744AQ53623499-88116A59-0460-4DEC-B999-5B30BC8FA070Q57671704-23BA2DBD-C46A-434F-B996-0C6A451F3213Q57734588-1259EDD2-56A5-47D6-9DFA-390ACEA13BB6
P2860
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diabetes and cancer (2): evalu ...... ality in patients with cancer.
@en
type
label
Diabetes and cancer (2): evalu ...... ality in patients with cancer.
@en
prefLabel
Diabetes and cancer (2): evalu ...... ality in patients with cancer.
@en
P2093
P2860
P1433
P1476
Diabetes and cancer (2): evalu ...... ality in patients with cancer.
@en
P2093
A G Renehan
Diabetes and Cancer Research Consortium
E A M Gale
J A Johnson
P2860
P2888
P304
P356
10.1007/S00125-012-2526-0
P577
2012-04-04T00:00:00Z
P5875
P6179
1025321777